Goldbohm R A, Hertog M G, Brants H A, van Poppel G, van den Brandt P A
Department of Epidemiology, Netherlands Organization for Applied Scientific Research [TNO] Nutrition and Food Research Institute, Zeist, The Netherlands.
J Natl Cancer Inst. 1996 Jan 17;88(2):93-100. doi: 10.1093/jnci/88.2.93.
Tea is one of the most frequently consumed beverages in the world. Antioxidant polyphenol compounds (such as catechins and flavonols) are abundantly present in both green and black teas and have been observed to have anticarcinogenic properties in cell and animal model studies. In black tea, however, most of the catechins have been oxidized to forms that may have reduced anticarcinogenic properties. Despite indications from experimental studies that tea may protect against cancer, epidemiologic evidence has been inconclusive.
The association between black tea consumption and the subsequent risk of stomach, colorectal, lung, and breast cancers was investigated in The Netherlands Cohort Study on Diet and Cancer among 58,279 men and 62,573 women aged 55-69 years.
Subjects in the cohort completed a self-administered questionnaire on dietary habits and other risk factors for cancer at base line in 1986. Follow-up for cancer was done by means of computerized record linkage with all nine regional cancer registries in The Netherlands and the national pathology database. During 4.3 years of follow-up, 200, 650, 764, and 650 cases of stomach, colorectal, lung, and breast cancers were diagnosed, respectively. The questionnaire data of case subjects and those of a random subcohort (n = 3500) were used to calculate rate ratios (RRs) of cancer in categories of consumers of black tea compared with nonconsumers.
Tea was not used by 13% of the subjects in the cohort, whereas 37%, 34%, and 16% consumed one to two, three to four, and five or more cups of tea per day, respectively. No association was observed between tea consumption and risk of colorectal cancer: The risk among tea drinkers in each consumption category was similar to that among nondrinkers. The RR of breast cancer among consumers of five or more cups of tea per day was 1.3 (95% confidence interval = 0.9-2.0); no dose-response association was observed. In age- and sex-adjusted analyses, consumption of tea was inversely associated with stomach (two-sided P for trend = .147) and lung (two-sided P for trend < .001) cancers. However, tea drinkers appeared to smoke less and to eat more vegetables and fruits than nondrinkers. When smoking and dietary factors were taken into account, tea in itself did not appear to protect against stomach and lung cancers: The RRs in all consumption categories were close to unity. Analysis of the tea and cancer relationship in a subgroup that included subjects in the lowest two quintiles of consumption of vegetables and fruits also failed to reveal a protective effect of tea consumption on the risk of three cancer types studied (colorectal, lung, and breast cancers).
This investigation does not support the hypothesis that consumption of black tea protects against four of the major cancers in humans; a cancer-enhancing effect was not evident, either.
茶是世界上最常饮用的饮品之一。抗氧化多酚化合物(如儿茶素和黄酮醇)在绿茶和红茶中均大量存在,并且在细胞和动物模型研究中已观察到其具有抗癌特性。然而,在红茶中,大多数儿茶素已被氧化成可能具有降低的抗癌特性的形式。尽管实验研究表明茶可能预防癌症,但流行病学证据尚无定论。
在荷兰饮食与癌症队列研究中,对58279名男性和62573名年龄在55至69岁之间的女性,调查饮用红茶与随后发生胃癌、结直肠癌、肺癌和乳腺癌风险之间的关联。
该队列中的受试者在1986年基线时完成了一份关于饮食习惯和其他癌症风险因素的自填问卷。通过与荷兰所有九个地区癌症登记处和国家病理数据库进行计算机化记录链接来进行癌症随访。在4.3年的随访期间,分别诊断出200例、650例、764例和650例胃癌、结直肠癌、肺癌和乳腺癌。病例受试者和一个随机子队列(n = 3500)的问卷数据用于计算饮用红茶者与不饮用者相比各类别癌症的发病率比(RRs)。
该队列中13%的受试者不饮茶,而分别有37%、34%和16%的受试者每天饮用一至两杯、三至四杯以及五杯或更多杯茶。未观察到饮茶与结直肠癌风险之间存在关联:每个饮茶类别中的饮茶者风险与不饮茶者相似。每天饮用五杯或更多杯茶的消费者中乳腺癌的RR为1.3(95%置信区间 = 0.9 - 2.0);未观察到剂量反应关联。在年龄和性别调整分析中,饮茶与胃癌(趋势的双侧P值 = 0.147)和肺癌(趋势的双侧P值 < 0.001)呈负相关。然而,饮茶者似乎比不饮茶者吸烟更少,且食用更多蔬菜和水果。当考虑吸烟和饮食因素时,茶本身似乎并不能预防胃癌和肺癌:所有饮茶类别的RR均接近1。在包括蔬菜和水果消费量处于最低两个五分位数受试者在内的亚组中,对茶与癌症关系的分析也未揭示饮茶对所研究的三种癌症类型(结直肠癌、肺癌和乳腺癌)风险具有保护作用。
这项调查不支持饮用红茶可预防人类四种主要癌症的假设;也未发现明显的癌症促进作用。